about
Cardiac Resynchronization Therapy Outcomes in Type 2 Diabetic Patients: Role of MicroRNA ChangesThe ictal bradycardia syndrome: A case report.Bariatric surgery reduces oxidative stress by blunting 24-h acute glucose fluctuations in type 2 diabetic obese patients.Cardiac electrophysiological alterations and clinical response in cardiac resynchronization therapy with a defibrillator treated patients affected by metabolic syndromeSerum oxidative stress markers and lipidomic profile to detect NASH patients responsive to an antioxidant treatment: a pilot study.Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients.Effects of PPARs agonists on cardiac metabolism in littermate and cardiomyocyte-specific PPAR-γ-knockout (CM-PGKO) mice.Potential role of TCF7L2 gene variants on cardiac sympathetic/parasympathetic activityMediterranean diet, telomere maintenance and health status among elderly.Association of genetic variation in adaptor protein APPL1/APPL2 loci with non-alcoholic fatty liver diseaseComorbidities and crash involvement among younger and older driversA/ASP/VAL allele combination of IGF1R, IRS2, and UCP2 genes is associated with better metabolic profile, preserved energy expenditure parameters, and low mortality rate in longevity.Serum CD26 levels in patients with gastric cancer: a novel potential diagnostic marker.Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition.Dipeptidyl peptidase 4 inhibition may facilitate healing of chronic foot ulcers in patients with type 2 diabetes.Awaking Blood Pressure Surge and Progression to Microalbuminuria in Type 2 Normotensive Diabetic Patients.Moderate-intensity statin therapy seems ineffective in primary cardiovascular prevention in patients with type 2 diabetes complicated by nephropathy. A multicenter prospective 8 years follow up studyShort-term effects of low-dose estrogen/drospirenone vs low-dose estrogen/dydrogesterone on glycemic fluctuations in postmenopausal women with metabolic syndrome.Dipeptidyl peptidase-4 inhibitors in the elderly: more benefits or risks?Cryptogenic stroke and diabetes: a probable link between silent atrial fibrillation episodes and cerebrovascular disease.Telemonitoring in heart failure patients treated by cardiac resynchronisation therapy with defibrillator (CRT-D): the TELECART Study.Sarcopenia in Elderly Diabetic Patients: Role of Dipeptidyl Peptidase 4 Inhibitors.The incidence of sarcopenia among hospitalized older patients: results from the Glisten study.Prevalence and Clinical Correlates of Sarcopenia, Identified According to the EWGSOP Definition and Diagnostic Algorithm, in Hospitalized Older People: The GLISTEN Study.Pancreatic cancer and diabetes: A two-way relationship in the perspective of diabetologist.Multipolar pacing by cardiac resynchronization therapy with a defibrillators treatment in type 2 diabetes mellitus failing heart patients: impact on responders rate, and clinical outcomes.Response to Comment on: Rizzo et al. Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition. Diabetes Care 2012;35:2076-2082.Changing the metabolic profile by large-volume liposuction: a clinical study conducted with 123 obese women.Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors.Role of free fatty acids on cardiac autonomic nervous system in noninsulin-dependent diabetic patients: effects of metabolic control.Low insulin resistance and preserved beta-cell function contribute to human longevity but are not associated with TH-INS genes.Glucose regulation and oxidative stress in healthy centenarians.Evidence for reduction of pro-atherosclerotic properties in platelets from healthy centenarians.The -8 UTR C/G polymorphism of PSMA6 gene is associated with susceptibility to myocardial infarction in type 2 diabetic patients.Peri-procedural tight glycemic control during early percutaneous coronary intervention up-regulates endothelial progenitor cell level and differentiation during acute ST-elevation myocardial infarction: effects on myocardial salvage.Resting metabolic rate and respiratory quotient in human longevity.Effects of vildagliptin twice daily vs. sitagliptin once daily on 24-hour acute glucose fluctuations.Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patients.Evidence for anti-inflammatory effects of combined administration of vitamin E and C in older persons with impaired fasting glucose: impact on insulin action.Arterial stiffness and cognition in elderly persons with impaired glucose tolerance and microalbuminuria.
P50
Q26774376-FE393F72-14EA-4A76-BF34-55F81FDCAB2FQ33165890-EE63F0FB-AC8D-451E-9C3D-90A2A7EE7518Q33602173-4444ACAE-C436-43A1-AD7C-D80A6533991AQ33621367-5FE96D5B-62F8-47D6-8BD5-BB1C2ACBE85EQ33765372-80A99FC8-F441-441B-89B9-18A38353D516Q34153437-F56A6BB2-0BB6-4ED3-8337-242B77546F13Q34259900-69ADD9A7-D76C-4755-9F35-3AA6BE719BD1Q34410188-D40594F9-AC09-451C-A643-3CF872E546CFQ34706826-E50964C2-F7A2-4322-918B-CEB74A6E362BQ34971028-DB8233C1-79AC-44DC-AFDB-406D1945FA6DQ35145566-6908029A-34D8-461E-AD88-F7B49BFF3E2AQ35678143-2B8313D3-4E0D-442F-834B-B86F7A7A0AC6Q35809359-DD2309AE-4F0F-43C0-85A8-542B94DE7351Q36249602-E3A11A19-92B4-4AF4-85AE-03AB00DF3464Q36415163-DA0313D1-A180-41B9-BAEA-E6801CA07B0BQ36448380-E895085C-D160-4276-AFBB-2FE3F67CB620Q37336662-84B1C75A-DA79-4E26-BBCE-D22F9E506F5CQ37471083-B0FA3731-2FDC-459D-B174-55F6D5310BDAQ37992956-EDA4DE53-710A-4F49-B68B-5876FE0368ACQ38181527-9E3A33C7-FF40-428B-84D4-7DB1984293C8Q39690351-C4B9B10A-7A30-4080-B78E-398AB10C496AQ39709537-58BB0D8F-7FF7-4862-A17F-0B2643931DDDQ40039365-3D54E164-FCAE-4658-9725-2B21F0C58F37Q40280146-173566F9-E9D6-41F7-9240-37C535AC3537Q40784414-7EFD19F0-AC7C-490E-AD8D-1CC09CD836D9Q42209367-6583BD05-8DFA-4339-881B-5E0703AA1469Q42419391-3E8CABA6-D56A-4434-A0A4-C66824260662Q42487425-1CD3C405-60CA-434A-9238-CA0B9AA07384Q42685736-7CECCBA2-E99B-44F4-978D-FEC7E67F89D8Q43633897-54D93F9A-247A-4721-8A9F-F70AC4D702EFQ43818726-546C6C09-439E-4514-9321-90461AE9FE07Q44288347-48697F24-FA57-4864-8D7D-2BF79953F6EFQ44387066-E2143D79-9562-4D46-BDB9-19F7D54A1999Q44604143-BC5842A7-6065-4444-98A3-7D356C1EA51CQ45012759-42C51967-BEB3-41AC-BADC-3787098135CAQ45105912-D98CC2EE-9644-4BDA-9F4E-96F820273BC4Q45217917-10A99BBB-D6B8-4784-B9F9-281CAC6B1AA7Q46048408-FD0B7664-E05D-445C-A56C-106F4630B058Q46269131-63E39A67-B340-47F3-9BC1-90093BE300B5Q46327115-B3669319-C786-4BE6-AC28-1B8BB181E168
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Maria Rosaria Rizzo
@ast
Maria Rosaria Rizzo
@en
Maria Rosaria Rizzo
@es
Maria Rosaria Rizzo
@nl
type
label
Maria Rosaria Rizzo
@ast
Maria Rosaria Rizzo
@en
Maria Rosaria Rizzo
@es
Maria Rosaria Rizzo
@nl
prefLabel
Maria Rosaria Rizzo
@ast
Maria Rosaria Rizzo
@en
Maria Rosaria Rizzo
@es
Maria Rosaria Rizzo
@nl
P106
P1153
7202023684
P21
P31
P496
0000-0002-1023-4260